Marshall Wace North America’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $261K | Sell |
3,227
-266
| -8% | -$21.5K | ﹤0.01% | 1224 |
|
|
2021
Q2 | $337K | Sell |
3,493
-10,114
| -74% | -$976K | ﹤0.01% | 1204 |
|
|
2021
Q1 | $1.64M | Sell |
13,607
-533
| -4% | -$64K | 0.01% | 868 |
|
|
2020
Q4 | $1.85M | Buy |
14,140
+8,125
| +135% | +$1.06M | 0.01% | 774 |
|
|
2020
Q3 | $634K | Buy |
6,015
+261
| +5% | +$27.5K | ﹤0.01% | 914 |
|
|
2020
Q2 | $1.48M | Sell |
5,754
-14,159
| -71% | -$3.64M | 0.01% | 657 |
|
|
2020
Q1 | $8.86M | Buy |
19,913
+7,123
| +56% | +$3.17M | 0.07% | 236 |
|
|
2019
Q4 | $8.65M | Buy |
+12,790
| New | +$8.65M | 0.04% | 314 |
|